Posted records profits today. Shares are surging today and so far this year. Nice top and bottom line beats and return on capital of 26% as they reduced debt below 15%. Also, they raised their share buyback. The oil supply/demand imbalance won't change for a while.
He just sold his Walmart. The news earlier this week cut guidance for full-year 2023. There's a shift on consumer sentiment. It trades at a forward 22x which is a premium to the market. That's why he sold. WM will figure things out but will take a quarter or two.
Staples are up YTD, but struggled in the past month. P&G's organic sales are slowing, 10% last quarter, 7% this, and guiding 3-5%. Shutdowns in China, high USD and reduced operations in Russia are reasons. 50% of sales are overseas so the strong dollar is headwind.
Struggling today after earnings. Organic sales did surprise, up 10%, while Latin American growth was over 12%. But multinationals with lots of overseas exposure will struggle against the high USD.
A great name in pharma that reported today. Their neuroscience division is up 14% quarter over quarter, while cash flow yield is above 7%. It's performed relatively well vs. the market YTD. He still likes the name.
It's down 74% off its peak, 54% YTD, a struggle. Let's see if this activist investor comes in and what he does. He does love their business model. Will watch the next few quarters.